R. Laduane Clifton - Net Worth and Insider Trading

R. Laduane Clifton Net Worth

The estimated net worth of R. Laduane Clifton is at least $91,415 dollars as of 2024-05-19. R. Laduane Clifton is the CFO, Secretary & Treasurer of Zevra Therapeutics Inc and owns about 15,309 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $72,412. R. Laduane Clifton is also the Chief Accounting Officer of LGL Group Inc and owns about 3,606 shares of LGL Group Inc (LGL) stock worth over $19,004. Details can be seen in R. Laduane Clifton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R. Laduane Clifton has not made any transactions after 2023-09-06 and currently still holds the listed stock(s).

Transaction Summary of R. Laduane Clifton

To

R. Laduane Clifton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R. Laduane Clifton owns 2 companies in total, including Zevra Therapeutics Inc (ZVRA) , and LGL Group Inc (LGL) .

Click here to see the complete history of R. Laduane Clifton’s form 4 insider trades.

Insider Ownership Summary of R. Laduane Clifton

Ticker Comapny Transaction Date Type of Owner
ZVRA Zevra Therapeutics Inc 2023-09-06 VP Fin & Corp Controller
LGL LGL Group Inc 2011-08-31 Chief Accounting Officer

R. Laduane Clifton Latest Holdings Summary

R. Laduane Clifton currently owns a total of 2 stocks. Among these stocks, R. Laduane Clifton owns 15,309 shares of Zevra Therapeutics Inc (ZVRA) as of September 6, 2023, with a value of $72,412 and a weighting of 79.21%. R. Laduane Clifton also owns 3,606 shares of LGL Group Inc (LGL) as of August 31, 2011, with a value of $19,004 and a weighting of 20.79%.

Latest Holdings of R. Laduane Clifton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZVRA Zevra Therapeutics Inc 2023-09-06 15,309 4.73 72,412
LGL LGL Group Inc 2011-08-31 3,606 5.27 19,004

Holding Weightings of R. Laduane Clifton


R. Laduane Clifton Form 4 Trading Tracker

According to the SEC Form 4 filings, R. Laduane Clifton has made a total of 22 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 22 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 1,000 shares on September 6, 2023, which cost R. Laduane Clifton around $4,960.

According to the SEC Form 4 filings, R. Laduane Clifton has made a total of 0 transactions in LGL Group Inc (LGL) over the past 5 years. The most-recent trade in LGL Group Inc is the acquisition of 51 shares on August 31, 2011, which cost R. Laduane Clifton around $393.

Insider Trading History of R. Laduane Clifton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

R. Laduane Clifton Trading Performance

GuruFocus tracks the stock performance after each of R. Laduane Clifton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R. Laduane Clifton is 10.18%. GuruFocus also compares R. Laduane Clifton's trading performance to market benchmark return within the same time period. The performance of stocks bought by R. Laduane Clifton within 3 months outperforms 10 times out of 29 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how R. Laduane Clifton's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of R. Laduane Clifton

Average Return

Average return per transaction

Outperforming Transactions

11 out of 28 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.09
Relative Return to S&P 500(%) 1.2

R. Laduane Clifton Ownership Network

Ownership Network List of R. Laduane Clifton

No Data

Ownership Network Relation of R. Laduane Clifton


R. Laduane Clifton Owned Company Details

What does Zevra Therapeutics Inc do?

Who are the key executives at Zevra Therapeutics Inc?

R. Laduane Clifton is the VP Fin & Corp Controller of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , CCO & EVP & Bus. Development Joshua Schafer , and VP & Corporate Controller Timothy J. Sangiovanni .

Zevra Therapeutics Inc (ZVRA) Insider Trades Summary

Over the past 18 months, R. Laduane Clifton made 4 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 6,100. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 3,500 shares made by Joshua Schafer , a net purchase of 1,000 shares made by Watton Corey Michael , and a net purchase of 20,000 shares made by John B Bode .

In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.

Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zevra Therapeutics Inc Insider Transactions

No Available Data

R. Laduane Clifton Mailing Address

Above is the net worth, insider trading, and ownership report for R. Laduane Clifton. You might contact R. Laduane Clifton via mailing address: C/o Kempharm, Inc., 1170 Celebration Blvd., #103, Celebration Fl 34747.

Discussions on R. Laduane Clifton

No discussions yet.